计算溶液所需的质量、体积或浓度。
Moligand™ 级 提供 ≥95% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
避光,-20°C储存。超低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Information
3BDO 3BDO, a butyrolactone derivative, could target FKBP1A and activate the mTOR signaling pathway. It inhibits autophagy in HUVECs. 3BDO inhibits oxLDL-induced apoptosis .
Targets
FKBP1A (Cell-free assay)
In vitro
3BDO inhibits autophagy in human umbilical vein endothelial cells (HUVECs) and neuronal cells. It suppresses lipopolysaccharide-induced HUVEC autophagic injury by downregulating the protein levels of NUPR1 (nuclear protein, transcriptional regulator) and TP53 (tumor protein p53), TP53 nuclear translocation and reactive oxygen species overproduction. 3BDO activates MTOR by targeting FKBP1A (FK506-binding protein 1A, 12 kDa). 3BDO greatly decreases the level of a long noncoding RNA (lncRNA) derived from the 3′ untranslated region (3′UTR) of TGFB2, known as FLJ11812, but does not affect TGFB2 expression. ATG13 protein level is decreased along with 3BDO-decreased FLJ11812 level. 3BDO inhibits excessive Aβ (25 to 35) peptide-induced autophagy in PC12 neuronal cells and increased the phosphorylation of RPS6KB1. 3BDO could inhibit human umbilical vein EC (HUVEC) apoptosis and senescence induced by deprivation of serum and basic fibroblast growth factor 2. iT selectively protecteS vascular ECs (VECs) and inhibitS vascular smooth muscle cell (VSMC) proliferation and migration. 3BDO (20-60 μg/ml) could inhibit VEC apoptosis and suppress integrin β4 expression, but it could not depress the ROS level induced by deprivation of serum and FGF-2.
In vivo
In vivo experiments showed that 3BDO had a good safety profile. 3BDO treatment could significantly reduce the number of autophagosomes and improve neuronal function in App and Psen1 transgenic mice. 3BDO activated mTOR in vivo and decreased the protein level of ATG13 in the plaque endothelium of apoE-/- mice. It does not affect the activity of mTOR and autophagy in macrophage cell line RAW246.7 and vascular smooth muscle cells of apoE-/- mice, but suppressed plaque endothelial cell death and restricted atherosclerosis development in the mice. 3BDO protecteS VECs by activating mTOR and thus stabilized atherosclerotic lesions in apoE-/- mice.
Cell Research(from reference)
Cell lines:HUVECs
Concentrations:60 μM
Incubation Time:24 h
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 苯类化合物 |
| 类(Class) | 苯及其取代衍生物 |
| 亚类(Subclass) | 硝基苯类 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 硝基苯醚 |
| 其他上位类(Alternative Parents) | 苯氧基化合物 酚醚 硝基芳香化合物 烷基芳基醚 γ-丁内酯 氧杂环戊烷 羧酸酯 炔丙基型1,3-偶极有机化合物 氧环化合物 有机氧氮化合物 一元羧酸及其衍生物 有机氮化合物 碳氢化合物衍生物 有机氧化物 有机盐 羰基化合物 有机阳离子 |
| 分子骨架(Molecular Framework) | 芳香族杂单环化合物 |
| 取代基(Substituents) | 芳基醚 - 烯丙基硫醚 - 芳香族杂单环化合物 - C-硝基化合物 - 羰基 - 羧酸衍生物 - 羧酸酰胺 - 乙醚 - γ-丁内酯 - 烃衍生物 - L-α-氨基酸 - 单羧酸或其衍生物 - 硝基芳烃化合物 - 硝基苯醚 - 有机1,3-双极性化合物 - 有机铵盐 - 有机硝基化合物 - 有机硝基化合物 - 有机氧化物 - 有机氧氮化合物 - 有机氧化合物 - 有机盐 - 有机杂环化合物 - 有机氮化合物 - 有机氧化合物 - 氧杂环 - 氧杂环丁烷 - 苯酚醚 - 苯氧基化合物 - 丙炔型1,3-双极性有机化合物 |
| 描述(Description) | 该化合物属于硝基苯醚类有机化合物。这类芳香化合物含有硝基苯基结构,其苯环上连接有醚基团。 |
| 外部描述符(External Descriptors) | 暂无 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
H302: 吞食有害
H315: 引起皮肤刺激
H319: 引起严重眼睛刺激
H335: 可能引起呼吸道刺激
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾
P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。